Energy Transfer Therapy in Treatment of Medial Gastrocnemius

NCT ID: NCT04325750

Last Updated: 2020-09-29

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 32 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-06-01
• Study Completion Date: 2020-08-28

Brief Summary

This study develops the effects of Capacitive and Resistive Energy Transfer Therapy (TECAR) on medial gastrocnemius using thermographic cameras, algometry and lunge tests, in a pre-post study with basketball players using a control group to which placebo is applied. (simulated technique) and an intervention group to which the technique is performed. The main objective of the study is to establish whether the TECAR produces physiological and mechanical changes in the subjects that improve muscle recovery.

Conditions

Strain of Gastrocnemius Muscle (Diagnosis); Diathermy Plate Burn; Thermography; Sports Physical Therapy

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Control

The simulated mode technique is applied (machine off)

Group Type: PLACEBO_COMPARATOR

Placebo

Intervention Type: OTHER

simulated TECAR Therapy (machine off)

TECAR THERAPY

The intervention will be performed with the T-Care TECAR® therapy machine at the latent trigger points of both gastrocnemius. The professional will apply the therapy with the generator that emits radio frequency signals of 0.5 MHz at a variable power with a maximum of 300W. The frequency to be used will be 500MHz with an intensity of 40% and with direct current.

Group Type: EXPERIMENTAL

TECAR Therapy

Intervention Type: PROCEDURE

The intervention will be performed with the T-Care TECAR® therapy machine at the latent trigger points of both gastrocnemius. The professional will apply the therapy with the generator that emits radio frequency signals of 0.5 MHz at a variable power with a maximum of 300W. The frequency to be used will be 500MHz with an intensity of 40% and with direct current.

Interventions

TECAR Therapy

The intervention will be performed with the T-Care TECAR® therapy machine at the latent trigger points of both gastrocnemius. The professional will apply the therapy with the generator that emits radio frequency signals of 0.5 MHz at a variable power with a maximum of 300W. The frequency to be used will be 500MHz with an intensity of 40% and with direct current.

Intervention Type: PROCEDURE

Placebo

simulated TECAR Therapy (machine off)

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Male players
• Semi-professional players who are currently active
• Not have suffered a lower limb injury in the last 6 months before the study
• Not having suffered a rupture of the triceps surae
• Contain a latent trigger point in the medial gastrocnemius

Exclusion Criteria

• Players suffering from any disease that could alter the study or be contradictory

• Minimum Eligible Age: 16 Years
• Maximum Eligible Age: 39 Years
• Eligible Sex: MALE
• Accepts Healthy Volunteers: No

Sponsors

Fundación Universidad Católica de Valencia San Vicente Mártir

OTHER

Sponsor Role: lead

Responsible Party

Carlos Barrios Pitarque

PhD. Dean of Faculty of Medicine and Health Sciences

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Carlos Barrios, PhD

Role: STUDY_DIRECTOR

Universidad Católica de Valencia San Vicente Mártir

Locations

Universidad Católica de Valencia San Vicente Mártir

Valencia, , Spain

Countries

Spain

Other Identifiers

UCV2017-2018-40

Identifier Type: -

Identifier Source: org_study_id